Brand  (β version)

  The number of atoms exceeds 100,000.
  So, it can not be displayed here.

Select unit:

Select hetatm:   

close
information
centroid:
interaction residue:

Select chain:   Sequence  

Data format:   

Color scheme of protein:

Ligands
Code Name Style Show Link
JWA N-({4-[3-(cyclopentylsulfamoyl)-4-methylphenyl]-3-methyl-1,2-oxazol-5-yl}methyl)acetamide
Non-standard Residues
Code Name Show
Glycosylation
Code Name Emphasize
Modification
Code Name Show
Code : 6MO7   PDBj   RCSB PDB   PDBe
Header : transcription/transcription inhibitor
Title : N-terminal bromodomain of human BRD2 with N-((4-(3-(N-cyclopentylsulfamoyl)-4-methylphenyl)-3-methylisoxazol-5-yl)methyl)acetamide inhibitor
Release Data : 2019-01-23
Compound :
mol_id molecule chains synonym
1 Bromodomain-containing protein 2 A,B,C O27.1.1,Really interesting new gene 3 protein
Source :
mol_id organism_scientific organism_common expression_system
1 Homo sapiens  (taxid:9606) Human Escherichia coli  (taxid:562)
gene: BRD2, KIAA9001, RING3
Authors : Lansdon, E.B., Newby, Z.E.R.
Keywords : Inhibitor, epigenetic reader, bromodomain, transcription-transcription inhibitor complex
Exp. method : X-RAY DIFFRACTION ( 1.85 Å )
Citation :

Structure-guided discovery of a novel, potent, and orally bioavailable 3,5-dimethylisoxazole aryl-benzimidazole BET bromodomain inhibitor.

Sperandio, D.,Aktoudianakis, V.,Babaoglu, K.  et al.
(2019)  Bioorg. Med. Chem.  27 : 457 - 469

PubMed: 30606676
DOI: 10.1016/j.bmc.2018.11.020

Chain : A, B, C
UniProt : P25440 (BRD2_HUMAN)
Reaction : -